Dermata Therapeutics, Inc. (NASDAQ:DRMA) Short Interest Down 57.0% in May
Dermata Therapeutics, Inc. (NASDAQ:DRMA – Get Free Report) saw a significant decline in short interest during the month of May. As of May 15th, there was short interest totalling 109,800 shares, a decline of 57.0% from the April 30th total of 255,100 shares. Currently, 2.2% of the shares of the company are sold short. Based […]
Dermata Therapeutics, Inc. (NASDAQ:DRMA – Get Free Report) saw a significant decline in short interest during the month of May. As of May 15th, there was short interest totalling 109,800 shares, a decline of 57.0% from the April 30th total of 255,100 shares. Currently, 2.2% of the shares of the company are sold short. Based […]
